NFKB1 and chronic kidney disease: In conclusion, our data demonstrated that CAT exhibited ameliorative effects against adenine-induced CKD in mice by mitigating inflammation and oxidative stress, which subsequently suppressed the occurrences of DNA damage and apoptosis and consequently led to the reduction of kidney injury markers and fibrosis through mechanisms involving sirtuin-1 activation and NF-κB inhibition.